320 related articles for article (PubMed ID: 16284279)
21. Differential role of CB1 and TRPV1 receptors on anandamide modulation of defensive responses induced by nitric oxide in the dorsolateral periaqueductal gray.
Lisboa SF; Guimarães FS
Neuropharmacology; 2012 Jun; 62(8):2455-62. PubMed ID: 22394688
[TBL] [Abstract][Full Text] [Related]
22. Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase.
Naidu PS; Kinsey SG; Guo TL; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2010 Jul; 334(1):182-90. PubMed ID: 20375198
[TBL] [Abstract][Full Text] [Related]
23. Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy.
Khasabova IA; Khasabov S; Paz J; Harding-Rose C; Simone DA; Seybold VS
J Neurosci; 2012 May; 32(20):7091-101. PubMed ID: 22593077
[TBL] [Abstract][Full Text] [Related]
24. The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nociceptive tone.
Olango WM; Roche M; Ford GK; Harhen B; Finn DP
Br J Pharmacol; 2012 Apr; 165(8):2549-60. PubMed ID: 21564082
[TBL] [Abstract][Full Text] [Related]
25. Cannabinoid 1 and transient receptor potential vanilloid 1 receptors discretely modulate evoked glutamate separately from spontaneous glutamate transmission.
Fawley JA; Hofmann ME; Andresen MC
J Neurosci; 2014 Jun; 34(24):8324-32. PubMed ID: 24920635
[TBL] [Abstract][Full Text] [Related]
26. Substance P drives endocannabinoid-mediated disinhibition in a midbrain descending analgesic pathway.
Drew GM; Lau BK; Vaughan CW
J Neurosci; 2009 Jun; 29(22):7220-9. PubMed ID: 19494144
[TBL] [Abstract][Full Text] [Related]
27. Analgesic effects of cannabinoid receptor agonist WIN55,212-2 in the nucleus cuneiformis in animal models of acute and inflammatory pain in rats.
Ebrahimzadeh M; Haghparast A
Brain Res; 2011 Oct; 1420():19-28. PubMed ID: 21911208
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin.
Engel MA; Izydorczyk I; Mueller-Tribbensee SM; Becker C; Neurath MF; Reeh PW
Neuropeptides; 2011 Jun; 45(3):229-37. PubMed ID: 21514666
[TBL] [Abstract][Full Text] [Related]
29. Opposing roles for cannabinoid receptor type-1 (CB₁) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in rats.
Casarotto PC; Terzian AL; Aguiar DC; Zangrossi H; Guimarães FS; Wotjak CT; Moreira FA
Neuropsychopharmacology; 2012 Jan; 37(2):478-86. PubMed ID: 21937980
[TBL] [Abstract][Full Text] [Related]
30. Evidence for both inverse agonism at the cannabinoid CB1 receptor and the lack of an endogenous cannabinoid tone in the rat and guinea-pig isolated ileum myenteric plexus-longitudinal muscle preparation.
Makwana R; Molleman A; Parsons ME
Br J Pharmacol; 2010 Jun; 160(3):615-26. PubMed ID: 20590566
[TBL] [Abstract][Full Text] [Related]
31. Effects of alterations in cannabinoid signaling, alone and in combination with morphine, on pain-elicited and pain-suppressed behavior in mice.
Miller LL; Picker MJ; Umberger MD; Schmidt KT; Dykstra LA
J Pharmacol Exp Ther; 2012 Jul; 342(1):177-87. PubMed ID: 22514333
[TBL] [Abstract][Full Text] [Related]
32. Corticosterone mediates reciprocal changes in CB 1 and TRPV1 receptors in primary sensory neurons in the chronically stressed rat.
Hong S; Zheng G; Wu X; Snider NT; Owyang C; Wiley JW
Gastroenterology; 2011 Feb; 140(2):627-637.e4. PubMed ID: 21070780
[TBL] [Abstract][Full Text] [Related]
33. The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanisms.
Bosier B; Muccioli GG; Lambert DM
Br J Pharmacol; 2013 Jun; 169(4):794-807. PubMed ID: 22970888
[TBL] [Abstract][Full Text] [Related]
34. Effects of glutamate NMDA and TRPV1 receptor antagonists on the biphasic responses to anandamide injected into the dorsolateral periaqueductal grey of Wistar rats.
Fogaça MV; Gomes FV; Moreira FA; Guimarães FS; Aguiar DC
Psychopharmacology (Berl); 2013 Apr; 226(3):579-87. PubMed ID: 23183551
[TBL] [Abstract][Full Text] [Related]
35. Cannabinoid receptor 1 suppresses transient receptor potential vanilloid 1-induced inflammatory responses to corneal injury.
Yang Y; Yang H; Wang Z; Varadaraj K; Kumari SS; Mergler S; Okada Y; Saika S; Kingsley PJ; Marnett LJ; Reinach PS
Cell Signal; 2013 Feb; 25(2):501-11. PubMed ID: 23142606
[TBL] [Abstract][Full Text] [Related]
36. Targeting the endocannabinoid system in the amygdala kindling model of temporal lobe epilepsy in mice.
Wendt H; Soerensen J; Wotjak CT; Potschka H
Epilepsia; 2011 Jul; 52(7):e62-5. PubMed ID: 21627644
[TBL] [Abstract][Full Text] [Related]
37. L-type calcium channel mediates anticonvulsant effect of cannabinoids in acute and chronic murine models of seizure.
Naderi N; Ahmad-Molaei L; Mazar-Atabaki A; Ronaghi A; Shirazi-zand Z; Motiei-Langroudi SM; Eslahkar S
Neurochem Res; 2012 Feb; 37(2):279-87. PubMed ID: 21928146
[TBL] [Abstract][Full Text] [Related]
38. Effects of COX-2 inhibition on spinal nociception: the role of endocannabinoids.
Staniaszek LE; Norris LM; Kendall DA; Barrett DA; Chapman V
Br J Pharmacol; 2010 Jun; 160(3):669-76. PubMed ID: 20590570
[TBL] [Abstract][Full Text] [Related]
39. Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice.
Gomes FV; Casarotto PC; Resstel LB; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):434-8. PubMed ID: 21111767
[TBL] [Abstract][Full Text] [Related]
40. Post-ictal analgesia in genetically epilepsy-prone rats is induced by audiogenic seizures and involves cannabinoid receptors in the periaqueductal gray.
Samineni VK; Premkumar LS; Faingold CL
Brain Res; 2011 May; 1389():177-82. PubMed ID: 21439272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
